High On-treatment Platelet Reactivity Identified by Multiple Platelet Function Assay

Summary

High on-treatment platelet reactivity to adenosine diphosphate was a important reason to cause ischemic events in antiplatelet therapy. Using single testing to definite HPR may miss the "true HPR" or over estimate HPR, which may lead to randomized trials failed. It is not known whether combined multiple platelet function testing could assist to ensure"ture"HPR and improve clinical outcomes.

Timeline

Start

2014-01

Primary completion

2015-08

Completion

2015-10

Drugs

Indications